CDH1 and thyroid cancer, nonmedullary, 2: Silencing of E-cadherin (CDH1) by its promoter methylation has been hypothesized as a potential mechanism of enhanced EMT in FTC cells, whereas in PTC cells, CDH1 expression levels are maintained (48, 49).